300347.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 03:04):

Stats
Today's Volume	16.33M
Average Volume	20.42M
Market Cap	35.54B
EPS	CNY0 ( 2024-04-22 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	22.48
ATR14	CNY0.0790 (0.15%)

Volume Correlation

Long: 0.03 (neutral)

Short: 0.04 (neutral)

Signal:(53.544) Neutral

Hangzhou Tigermed Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hangzhou Tigermed Correlation - Currency/Commodity

-0.35
( neutral )

0.23
( neutral )

0.00
( neutral )

-0.53
( weak negative )

-0.38
( neutral )

0.49
( neutral )

Hangzhou Tigermed Financials

Annual	2023
Revenue:	CNY7.36B
Gross Profit:	CNY2.69B (36.63 %)
EPS:	CNY2.34

Q4	2023
Revenue:	CNY1.73B
Gross Profit:	CNY529.30M (30.65 %)
EPS:	CNY0.170

Q3	2023
Revenue:	CNY1.94B
Gross Profit:	CNY798.47M (41.17 %)
EPS:	CNY0.560

Q2	2023
Revenue:	CNY1.91B
Gross Profit:	CNY765.56M (40.16 %)
EPS:	CNY0.940

Financial Reports:

No articles found.

Hangzhou Tigermed

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.